Aprogen Medicines Market Cap

Aprogen Medicines has a market cap or net worth of 98.73 billion as of March 13, 2026. Its market cap has decreased by -53.42% in one year.

Market Cap

98.73B

Enterprise Value

552.31B

Revenue

126.09B

Ranking

n/a

PE Ratio

n/a

Stock Price

306.00

Market Cap Chart

Since December 7, 1995, Aprogen Medicines's market cap has increased from 19.56B to 98.73B, an increase of 404.78%. That is a compound annual growth rate of 5.49%.

Market Cap History

Date	Market Cap	% Change
Mar 12, 2026	98.73B	-54.09%
Dec 30, 2025	215.06B	-2.20%
Dec 30, 2024	219.89B	-6.16%
Dec 28, 2023	234.32B	-41.38%
Dec 27, 2022	399.71B	19.11%
Dec 30, 2021	335.57B	-10.30%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samyang Holdings	500.10B
KG Chemical	367.76B
KPX Holdings	309.98B
HS HYOSUNG	216.81B
JLK, Inc.	179.98B
Woongjin	169.81B
Gridwiz	154.49B
HLB GLOBAL	99.59B

Market Cap Rankings